Sanko Junyaku, Eisai and Fujirebio Sign Joint Research Agreement for Development of New KL-6 Test Kit.
Sanko Junyaku currently manufactures and markets two test kits for interstitial pneumonia, EITEST KL-6 (sandwich enzyme immunoassay method) and PICOLUMI KL-6 (electrochemiluminescence immunoassay) for measurement of KL-6, a serum marker that is highly distinctive for the diagnosis of the disease, under a sales agreement with Eisai. With this new agreement, the three companies aim to develop a new KL-6 test kit compatible with diagnosis by LUMIPULSE systems, allowing for greater ease of use in diagnosis of interstitial pneumonia.
Fujirebio markets three automatic chemiluminescent enzyme immunoassay systems, LUMIPULSEf, LUMIPULSE S and LUMIPULSE Presto II. Today, more than 1000 LUMIPULSE systems have been used in medical institutions throughout Japan. The development of a new KL-6 test kit will further extend the measurement items of the LUMIPULSE systems, giving them the higher diagnostic capability.
Under today's agreement, the new KL-6 test kit will be manufactured by Fujirebio, while Sanko Junyaku and Eisai will be responsible for marketing and sales of the products.
Typical types of interstitial pneumonia include cryptogenic interstitial pneumonia and drug-induced pneumonia, both of which are designated as intractable disorders. Furthermore, cases of drug-induced pneumonia have been increasing recently, raising the significance of and public concern about this disease. Sanko Junyaku, Eisai and Fujirebio are committed to increasing benefits to patients and their families through the development of the new test kit.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Oct 19, 2006|
|Previous Article:||Siam United Steel Becomes Consolidated Subsidiary of Nippon Steel.|
|Next Article:||Sanko Lifetech Transfers Animal Health Products Business to Novartis Animal Health.|